|
Dynex diversifies risk by investing across the spectrum in biotechnology.
Dynex further diversifies risk by investing in a balanced mix of early stage and
mature biotechnologies. The Dynex portfolio includes the following:
- Revenue producing companies needing capital to expand;
- Earlier stage companies who have stable technologies ready to go to market;
and
- Earlier stage companies who are still developing their technology.
Dynex is a value-based investor with an eye on the fundamentals. We look for
opportunities to create strong business models. The markets must be large and
growing. The technology or product should be globally competitive.
|
